Last reviewed · How we verify
Fluarix vaccine
Fluarix vaccine is a Biologic drug developed by GlaxoSmithKline. It is currently FDA-approved.
Fluarix, a vaccine marketed by GlaxoSmithKline, holds a significant position in the influenza vaccine market. A key strength is the protection of its key composition patent, which is set to expire in 2028, providing a period of market exclusivity. The primary risk is the competitive landscape, with multiple other influenza vaccines available from different manufacturers.
At a glance
| Generic name | Fluarix vaccine |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP) (PHASE1)
- A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults (PHASE3)
- Opioid, HIV and Immune System (PHASE4)
- Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
- A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above (PHASE2)
- BPL-1357 Against H1N1 Influenza Virus Challenge (PHASE2)
- A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults (PHASE1)
- Vaccine Pandemic Preparedness Through Airway Immunology Characterization (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fluarix vaccine CI brief — competitive landscape report
- Fluarix vaccine updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI
Frequently asked questions about Fluarix vaccine
What is Fluarix vaccine?
Who makes Fluarix vaccine?
What development phase is Fluarix vaccine in?
Related
- Manufacturer: GlaxoSmithKline — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing